Health Technology Assessment of Paediatric Medicines

c4c have published ‘Health technology assessment of paediatric medicines: European landscape, challenges and opportunities inside the conect4children project” in British Journal of Clinical Pharmacology.   “The medicine development process is complex and requires time and effort to ensure safety, efficacy and quality. In paediatrics, this process is even more challenging, as it involves a subgroup of…

Details

Spotlight on a National Hub: Spain

Back in November 2016, the first meeting for the constitution of RECLIP was held at La Paz Research Institute in Madrid (IdiPAZ). By that time, the network consisted of 12 reference hospitals, the Foundation for the Promotion of Health and Biomedical Research (FISABIO) and 2 research networks RITIP (Translational Research Network in Pediatric Infectious Diseases)…

Details

How patients can be involved in paediatric clinical trials at regulatory level? (Interview with EURORDIS-Rare Diseases Europe)

Maria Cavaller (Patient Engagement Manager) and Gulcin Gumus (Research and Policy Project Manager) are from patient organisation EURORDIS-Rare Diseases Europe, which is a c4c project partner. We talked to them about how patient organizations can take part in the c4c project, the importance of engaging young patients in research and having patients as equal partners…

Details

Christmas message from the c4c Project Leadership Team

c4c is a success. During 2021 c4c actions have influenced other organizations and shown why c4c is important. Despite many difficulties, c4c is very effective because of the dedication by everyone who works on c4c. The hard work and dedication are paying off as we follow the c4c vision and mission. The impacts made by…

Details